GET THE APP

Method development and validation of amlodipine besylate and hydrochlorothiazide in their bulk and combined dosage form | Abstract
Scholars Research Library

Scholars Research Library

A-Z Journals

+44 7389645282

Der Pharmacia Lettre

Abstract

Method development and validation of amlodipine besylate and hydrochlorothiazide in their bulk and combined dosage form

Author(s): Ghodke Deepa. Vyankatrao, Bhusnure Omprakash, Kulkarni Aditi Anil

A simple, specific, accurate and precise reverse phase high pressure liquid chromatographic method has been developed for the determination of Amlodipine Besylate and Hydrochlorothiazide in bulk and combined dosage form by RP- HPLC using Hypersil BDS C18 column (Dimention : 250mmx 4.6mm, 5μ). The sample was analysed using Acetonitrile:Water 50:50% v/v mobile phase at a flow rate of 1.0ml/min and detection at 254nm. The retention time for Amlodipine Besylate and Hydrochlorothiazide was found to be 1.9 and 3.2 min respectively, and recoveries from combined dosage form were between 100.2% and 99.17%. The method can be used for routine analysis of Amlodipine Besylate and Hydrochlorothiazide in bulk and combined dosage form.